Recently, BMV ANIMAL TECHNOLOGIES (hereinafter referred to as “BMV”) received exciting news: in accordance with the relevant provisions of the national Administrative Measures for the Recognition of High-Tech Enterprises and Guidelines for the Recognition and Management of High-Tech Enterprises, the company has successfully passed the rigorous review and recognition process, officially being awarded the title of “National High-Tech Enterprise” and listed in the national directory of high-tech enterprises. This milestone marks the national authoritative recognition of BMV’s technological innovation capabilities and core competitiveness in the field of pet medical equipment.
The certification of National High-Tech Enterprise is a comprehensive evaluation of enterprises in multiple dimensions, including core independent intellectual property rights, scientific and technological achievement transformation capabilities, R&D organization and management level, and growth potential, representing the advanced level of domestic enterprises in the high-tech field. BMV’s successful recognition is not only a high affirmation of the company’s long-term commitment to technological innovation, but also an endorsement of its professional accumulation in the R&D of pet medical equipment – from tackling key core technologies and upgrading product iterations to building R&D teams and transforming scientific and technological achievements, all of which meet the stringent standards of national key supported high-tech enterprises.

As an enterprise focused on innovating pet medical equipment, BMV has always placed technological R&D at the core of its development. Relying on a R&D team composed of highly educated scientific and technological talents, the company continuously invests in R&D resources, focuses on the actual needs of veterinarians worldwide in clinical diagnosis and treatment, overcomes multiple technical challenges, and drives the development of pet medical equipment towards precision, intelligence, and portability. The acquisition of the “National High-Tech Enterprise” certificate will bring multiple development advantages to BMV: in terms of taxation, the company can enjoy a preferential policy of reducing the corporate income tax rate from 25% to 15% for three consecutive years, providing financial support for sustained R&D investment; in terms of brand and market, this qualification will significantly enhance the company’s brand influence, laying a solid foundation for product bidding and global market expansion.

In response to this honor, a relevant person in charge of BMV ANIMAL TECHNOLOGIES stated: “Obtaining the National High-Tech Enterprise certification is both an incentive and a responsibility. Taking this as a new starting point, we will further increase R&D investment, deepen core technological innovation, and continuously optimize the product matrix of pet medical equipment. In the future, BMV will always adhere to the mission of ’empowering global veterinarians’, bringing advanced pet medical technologies and equipment to veterinary practitioners and pet groups in more countries and regions, and injecting new momentum into the high-quality development of the global pet medical industry.”
Being awarded the “National High-Tech Enterprise” certification is an important milestone in BMV’s development journey. Going forward, the company will give full play to the exemplary and leading role of a high-tech enterprise, drive development through technological innovation, serve the market with professional products, continue to make breakthroughs in the field of pet medical equipment, and write a new chapter in empowering global pet medical care.

Leave a Reply

Your email address will not be published. Required fields are marked *